Skip to content

Effects of Interior Space Using Cedar Wood on Cognitive Function, Sleep Symptoms, and Psychological Responses of aging residents, open label, placebo controlled, cross-over trial

Effects of Interior Space Using Cedar Wood on Cognitive Function, Sleep Symptoms, and Psychological Responses of aging residents, open label, placebo controlled, cross-over trial - Effect of cedar interior materials on aging residents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050873
Enrollment
10
Registered
2023-05-01
Start date
2023-09-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy older adults

Interventions

Use cedar board panels for interior materials for 6 weeks Use plastic plate panels for interior materials for 6 weeks

Sponsors

Graduate School of Kyushu University Faculty of Agriculture
Lead Sponsor
Cedar. Co., Ltd. Pine. Co., Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) persons who is generally judged as healthy (2) Persons who can give voluntary written consent to participate in the present trial (3) Persons who have cognitive functions that can be subjectively evaluated

Exclusion criteria

Exclusion criteria: (1) persons who have been directed not to participate for their illness or prevention from their doctor (2) persons with their medical histories of mental illness (3) persons who have severe sleep disorders (4) persons with their medical histories of brain desease (5) persons with their medical histories of alcohol or drug dependence (6) persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficacy with the effect evaluated in this study (7) persons who had already participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device)

Design outcomes

Primary

MeasureTime frame
Percentage of normal range of total TDAS points (between 0 points and 6 points) in dementia screening secondary test.

Secondary

MeasureTime frame
Change from baseline in sleep checker good sleep rate, total point of geriatological depression rating scale, and total point of subjective well-being scale.

Countries

Japan

Contacts

Public ContactMasumi Nagae

Graduate School of Kyushu University Faculty of Agriculture Department of Agro-Environmental Sciences Laboratory of Systematic Forest and Forest Products Scien

nagae.masumi.258@m.kyushu-u.ac.jp092-802-4946

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026